- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medicare Rewards for Process, Patient Satisfaction Not Always Linked to Better Outcomes
The movement to improve hospital quality has long assumed that close adherence to best medical practices leads to better outcomes. But a Modern Healthcare analysis of Medicare's first stabs at rewarding hospitals that do well on process-of-care measures and a patient-satisfaction survey while penalizing hospitals with high readmission rates shows only a minor correlation between the two.
The analysis, which uses Medicare's initial results for the value-based purchasing and readmissions reduction programs, also shows that hundreds of hospitals that did well in one program were penalized in the other. Dozens of hospitals that got the highest marks for avoiding readmissions were heavily penalized for their performance on process and patient satisfaction, while dozens more that received the maximum penalty for high 30-day readmission rates got high marks on key processes and attention to patients.
Read the full story: http://bit.ly/1181YAq
Source: ModernHealthcare.com
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
